Abatacept With Methotrexate- Phase IIB

NCT00162266 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

524

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept (BMS-188667)
DRUG: Abatacept (BMS-188667)
DRUG: Abatacept (BMS-188667)
DRUG: Placebo

Sponsor

Bristol-Myers Squibb